260 related articles for article (PubMed ID: 27555543)
21. Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer center.
Murthy SS; Sandhya DG; Ahmed F; Goud KI; Dayal M; Suseela K; Rajappa SJ
Indian J Pathol Microbiol; 2011; 54(3):532-8. PubMed ID: 21934215
[TBL] [Abstract][Full Text] [Related]
22. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
[TBL] [Abstract][Full Text] [Related]
23. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
[TBL] [Abstract][Full Text] [Related]
24. Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital.
Dong J; Ly A; Arpin R; Ahmed Q; Brachtel E
Breast Cancer Res Treat; 2016 Jul; 158(2):297-305. PubMed ID: 27383478
[TBL] [Abstract][Full Text] [Related]
25. SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients.
D'Alfonso TM; Liu YF; Chen Z; Chen YB; Cimino-Mathews A; Shin SJ
J Clin Pathol; 2013 May; 66(5):409-14. PubMed ID: 23386665
[TBL] [Abstract][Full Text] [Related]
26. Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer.
Gupta S; Mani NR; Carvajal-Hausdorf DE; Bossuyt V; Ho K; Weidler J; Wong W; Rhees B; Bates M; Rimm DL
Lab Invest; 2018 Aug; 98(8):1076-1083. PubMed ID: 29858579
[TBL] [Abstract][Full Text] [Related]
27. Preoperative assessment of HER-2/neu status in breast carcinoma: the role of quantitative real-time PCR on core-biopsy specimens.
Susini T; Bussani C; Marini G; Nori J; Olivieri S; Molino C; Bianchi S; Vezzosi V; Paglierani M; Giachi M; Borrani E; Scarselli G
Gynecol Oncol; 2010 Feb; 116(2):234-9. PubMed ID: 19919879
[TBL] [Abstract][Full Text] [Related]
28. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis.
Wang M; He X; Chang Y; Sun G; Thabane L
Breast; 2017 Feb; 31():157-166. PubMed ID: 27866091
[TBL] [Abstract][Full Text] [Related]
29. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.
Pegolo E; Machin P; Riosa F; Bassini A; Deroma L; Di Loreto C
Cancer Cytopathol; 2012 Jun; 120(3):196-205. PubMed ID: 22298467
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH).
Arnould L; Roger P; Macgrogan G; Chenard MP; Balaton A; Beauclair S; Penault-Llorca F
Mod Pathol; 2012 May; 25(5):675-82. PubMed ID: 22222637
[TBL] [Abstract][Full Text] [Related]
31. Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.
Bulte JP; Halilovic A; Kalkman S; van Cleef PHJ; van Diest PJ; Strobbe LJA; de Wilt JHW; Bult P
Histopathology; 2018 Jul; 73(1):81-89. PubMed ID: 29495112
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the IHC, FISH, SISH and qPCR methods for the molecular diagnosis of breast cancer.
Tvrdík D; Staněk L; Skálová H; Dundr P; Velenská Z; Povýšil C
Mol Med Rep; 2012 Aug; 6(2):439-43. PubMed ID: 22614884
[TBL] [Abstract][Full Text] [Related]
33. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.
Munch-Petersen HD; Rasmussen BB; Balslev E
APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587
[TBL] [Abstract][Full Text] [Related]
34. HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer.
Bozzetti C; Nizzoli R; Guazzi A; Flora M; Bassano C; Crafa P; Naldi N; Cascinu S
Ann Oncol; 2002 Sep; 13(9):1398-403. PubMed ID: 12196365
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
36. [Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].
Lee JW; Noh WC; Kim MS; Kim HA; Chang YH; Hong YJ; Hong SI; Lee JK
Korean J Lab Med; 2008 Oct; 28(5):392-9. PubMed ID: 18971621
[TBL] [Abstract][Full Text] [Related]
37. Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast.
Lee AH; Key HP; Bell JA; Hodi Z; Ellis IO
Histopathology; 2012 May; 60(6):880-4. PubMed ID: 22320892
[TBL] [Abstract][Full Text] [Related]
38. Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?
Rakha EA; Pigera M; Shin SJ; D'Alfonso T; Ellis IO; Lee AH
Histopathology; 2016 Jul; 69(1):20-4. PubMed ID: 26542743
[TBL] [Abstract][Full Text] [Related]
39. Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Dekker TJ; Smit VT; Hooijer GK; Van de Vijver MJ; Mesker WE; Tollenaar RA; Nortier JW; Kroep JR
Ann Oncol; 2013 Apr; 24(4):931-7. PubMed ID: 23211940
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens.
Gu M; Ghafari S; Zhao M
Acta Cytol; 2005; 49(5):471-6. PubMed ID: 16334021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
